NeoStem to Present at Multiple January Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
Aegis Capital Boosts PT on Neostem (NBS) to $23; Positive AMR-001 Phase 2 is Potential Value Driver
January 2, 2014 10:58 AM ESTAegis Capital maintains its Buy rating on NeoStem, Inc. (Nasdaq: NBS), but raises its price target from $21 up to $23.
Analyst Ram Selvaraju noted that the price target change on NeoStem was based fundamentally upon the progress made recently with the Athelos technology in the domain of... More
